These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 30867489)
21. Risperidone attenuates and reverses hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats. Shioda K; Nisijima K; Yoshino T; Kuboshima K; Iwamura T; Yui K; Kato S Neurotoxicology; 2008 Nov; 29(6):1030-6. PubMed ID: 18722468 [TBL] [Abstract][Full Text] [Related]
22. Ethanol-ecstasy (MDMA) interactions in rats: preserved attenuation of hyperthermia and potentiation of hyperactivity by ethanol despite prior ethanol treatment. Hamida SB; Bach S; Plute E; Jones BC; Kelche C; Cassel JC Pharmacol Biochem Behav; 2006 May; 84(1):162-8. PubMed ID: 16750260 [TBL] [Abstract][Full Text] [Related]
23. The role of the sympathetic nervous system and uncoupling proteins in the thermogenesis induced by 3,4-methylenedioxymethamphetamine. Mills EM; Rusyniak DE; Sprague JE J Mol Med (Berl); 2004 Dec; 82(12):787-99. PubMed ID: 15602689 [TBL] [Abstract][Full Text] [Related]
24. Studies on the mechanisms underlying amiloride enhancement of 3,4-methylenedioxymethamphetamine-induced serotonin depletion in rats. Goñi-Allo B; Puerta E; Hervias I; Di Palma R; Ramos M; Lasheras B; Aguirre N Eur J Pharmacol; 2007 May; 562(3):198-207. PubMed ID: 17320075 [TBL] [Abstract][Full Text] [Related]
25. Serotonin mediates rapid changes of striatal glucose and lactate metabolism after systemic 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") administration in awake rats. Gramsbergen JB; Cumming P Neurochem Int; 2007 Jul; 51(1):8-15. PubMed ID: 17475367 [TBL] [Abstract][Full Text] [Related]
26. Role of serotonin and/or norepinephrine in the MDMA-induced increase in extracellular glucose and glycogenolysis in the rat brain. Pachmerhiwala R; Bhide N; Straiko M; Gudelsky GA Eur J Pharmacol; 2010 Oct; 644(1-3):67-72. PubMed ID: 20633550 [TBL] [Abstract][Full Text] [Related]
27. The hyperthermic and neurotoxic effects of 'Ecstasy' (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype. Colado MI; Williams JL; Green AR Br J Pharmacol; 1995 Aug; 115(7):1281-9. PubMed ID: 7582557 [TBL] [Abstract][Full Text] [Related]
29. Effect of ambient temperature and a prior neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA) on the hyperthermic response of rats to a single or repeated ('binge' ingestion) low dose of MDMA. Green AR; Sanchez V; O'Shea E; Saadat KS; Elliott JM; Colado MI Psychopharmacology (Berl); 2004 May; 173(3-4):264-9. PubMed ID: 14726996 [TBL] [Abstract][Full Text] [Related]
30. Cutaneous vasoconstriction contributes to hyperthermia induced by 3,4-methylenedioxymethamphetamine (ecstasy) in conscious rabbits. Pedersen NP; Blessing WW J Neurosci; 2001 Nov; 21(21):8648-54. PubMed ID: 11606652 [TBL] [Abstract][Full Text] [Related]
31. Unilateral infusion of a dopamine transporter antisense into the substantia nigra protects against MDMA-induced serotonergic deficits in the ipsilateral striatum. Kanthasamy A; Sprague JE; Shotwell JR; Nichols DE Neuroscience; 2002; 114(4):917-24. PubMed ID: 12379247 [TBL] [Abstract][Full Text] [Related]
32. Hyperthermia induced by 3,4-methylenedioxymethamphetamine in unrestrained rhesus monkeys. Taffe MA; Lay CC; Von Huben SN; Davis SA; Crean RD; Katner SN Drug Alcohol Depend; 2006 May; 82(3):276-81. PubMed ID: 16289931 [TBL] [Abstract][Full Text] [Related]
33. Concurrent Inhibition of Vesicular Monoamine Transporter 2 Does Not Protect Against 3,4-Methylenedioxymethamphetamine (Ecstasy) Induced Neurotoxicity. Cholanians AB; Phan AV; Lau SS; Monks TJ Toxicol Sci; 2019 Jul; 170(1):157-166. PubMed ID: 30923810 [TBL] [Abstract][Full Text] [Related]
34. Clinically Relevant Pharmacological Strategies That Reverse MDMA-Induced Brain Hyperthermia Potentiated by Social Interaction. Kiyatkin EA; Ren S; Wakabayashi KT; Baumann MH; Shaham Y Neuropsychopharmacology; 2016 Jan; 41(2):549-59. PubMed ID: 26105141 [TBL] [Abstract][Full Text] [Related]
35. Protection against 3,4-methylenedioxymethamphetamine-induced neurodegeneration produced by glutathione depletion in rats is mediated by attenuation of hyperthermia. O'Shea E; Easton N; Fry JR; Green AR; Marsden CA J Neurochem; 2002 May; 81(4):686-95. PubMed ID: 12065628 [TBL] [Abstract][Full Text] [Related]
36. Acute administration of 3,4-methylenedioxymethamphetamine induces profound hyperthermia, blood-brain barrier disruption, brain edema formation, and cell injury. Sharma HS; Ali SF Ann N Y Acad Sci; 2008 Oct; 1139():242-58. PubMed ID: 18991870 [TBL] [Abstract][Full Text] [Related]
37. Effect of ambient temperature on hyperthermia and hyperkinesis induced by 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") in rats. Dafters RI Psychopharmacology (Berl); 1994 Apr; 114(3):505-8. PubMed ID: 7855209 [TBL] [Abstract][Full Text] [Related]
38. The effects of ecstasy (MDMA) on rat liver bioenergetics. Rusyniak DE; Tandy SL; Kamendulis LM; Sprague JE; Klaunig JE Acad Emerg Med; 2004 Jul; 11(7):723-9. PubMed ID: 15231458 [TBL] [Abstract][Full Text] [Related]
39. 3,4-Methylenedioxymethamphetamine- and 8-hydroxy-2-di-n-propylamino-tetralin-induced hypothermia: role and location of 5-hydroxytryptamine 1A receptors. Rusyniak DE; Zaretskaia MV; Zaretsky DV; DiMicco JA J Pharmacol Exp Ther; 2007 Nov; 323(2):477-87. PubMed ID: 17702902 [TBL] [Abstract][Full Text] [Related]
40. Distribution of temperature changes and neurovascular coupling in rat brain following 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") exposure. Coman D; Sanganahalli BG; Jiang L; Hyder F; Behar KL NMR Biomed; 2015 Oct; 28(10):1257-66. PubMed ID: 26286889 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]